Radiopharmaceutical Market: Growing at a Cagr of 8.8% Between 2016 and 2021

Published By: Zion Market Research

Radiopharmaceutical Market by Type (Diagnostic Radiopharmaceuticals and
Therapeutic radiopharmaceuticals), for Cardiology, Neurology, Oncology and Other
Applications- Global Industry Perspective, Comprehensive Analysis, Size, Share,
Growth, Segment, Trends and Forecast, 2015 – 2021

Contact Us:
4283, Express Lane, Suite 634-143,
Sarasota, Florida 34249, United States
Tel: +1-386-310-3803 GMT
Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651

sales@zionmarketresearch.com

Radiopharmaceutical Market

Zion Research has published a new report titled “Radiopharmaceutical Market by Type
(Diagnostic Radiopharmaceuticals and Therapeutic radiopharmaceuticals), for Cardiology,
Neurology, Oncology and Other Applications- Global Industry Perspective, Comprehensive
Analysis, Size, Share, Growth, Segment, Trends and Forecast, 2015 – 2021”. According to
the report, global demand for radiopharmaceutical market was valued at around USD 4.32
billion in 2015, is expected to reach approximately USD 7.13 billion in 2021 growing at a
CAGR of more than 8.8% between 2016 and 2021.
Radiopharmaceutical is a medication used in nuclear medicine that has radioactive part and
pharmaceutical part. Nuclear medication is given to a patient in a small amount; this makes
patient body radioactive for short time span. A special nuclear medicine camera detects the
radiation emitted from the body, and takes images on inner body organs to check its
function. Most of the radiopharmaceuticals used in diagnostic nuclear medicine procedures
emit gamma radiation. The most commonly used gamma emitting radionuclide in nuclear
medicine is 99mTechnetium, which is labeled to different types of pharmaceuticals to
formulate diagnostic imaging agent’s i.e radiopharmaceuticals.
Browse
the
full
"Radiopharmaceutical
Market
by
Type
(Diagnostic
Radiopharmaceuticals and Therapeutic radiopharmaceuticals), for Cardiology,
Neurology,...